Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drazer

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|April 24, 2002
Exact expression for the diffusion propagator in a family of time-dependent anharmonic potentialsJ A Giampaoli, D E Strier, C Batista, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United StatesMichael W Drazer, Dezheng Huo, Mara A Schonberg, et al.
Journal of Genetic Counseling|January 15, 2023
Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignanciesGregory W Roloff, Reid Shaw, Timothy E O'Connor, et al.
Current Hematologic Malignancy Reports|September 28, 2018
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and ControversiesImo J Akpan, Afaf E G Osman, Michael W Drazer, et al.
Ejhaem|September 2, 2022
<i>NPM1</i> exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoringPeng Wang, Jeremy Segal, Michael W Drazer, et al.
Annals of Surgical Oncology|March 19, 2024
ASO Author Reflections: Venous Thromboembolism in Peritoneal MesotheliomaVarun V Bansal, Owen Mitchell, Michael W Drazer, et al.
Leukemia & Lymphoma|June 9, 2023
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromesAdam Hamidi, Gregory W Roloff, Reid Shaw, et al.
JAMA|April 27, 2012
2008 US Preventive Services Task Force recommendations and prostate cancer screening ratesSandip M Prasad, Michael W Drazer, Dezheng Huo, et al.
Expert Review of Anticancer Therapy|April 15, 2016
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?Michael W Drazer, Joseph K Salama, Olwen M Hahn, et al.
JCO Oncology Practice|March 7, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Clinical InsightsHedy L Kindler, Ibiayi Dagogo-Jack, Marc de Perrot, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|April 24, 2002
Exact expression for the diffusion propagator in a family of time-dependent anharmonic potentialsJ A Giampaoli, D E Strier, C Batista, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United StatesMichael W Drazer, Dezheng Huo, Mara A Schonberg, et al.
Journal of Genetic Counseling|January 15, 2023
Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignanciesGregory W Roloff, Reid Shaw, Timothy E O'Connor, et al.
Current Hematologic Malignancy Reports|September 28, 2018
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and ControversiesImo J Akpan, Afaf E G Osman, Michael W Drazer, et al.
Ejhaem|September 2, 2022
<i>NPM1</i> exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoringPeng Wang, Jeremy Segal, Michael W Drazer, et al.
Annals of Surgical Oncology|March 19, 2024
ASO Author Reflections: Venous Thromboembolism in Peritoneal MesotheliomaVarun V Bansal, Owen Mitchell, Michael W Drazer, et al.
Leukemia & Lymphoma|June 9, 2023
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromesAdam Hamidi, Gregory W Roloff, Reid Shaw, et al.
JAMA|April 27, 2012
2008 US Preventive Services Task Force recommendations and prostate cancer screening ratesSandip M Prasad, Michael W Drazer, Dezheng Huo, et al.
Expert Review of Anticancer Therapy|April 15, 2016
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?Michael W Drazer, Joseph K Salama, Olwen M Hahn, et al.
JCO Oncology Practice|March 7, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Clinical InsightsHedy L Kindler, Ibiayi Dagogo-Jack, Marc de Perrot, et al.
Pageof 11